A frame shifted disulfide bridged analogue of angiotensin II

Bioorg Med Chem. 2003 Mar 20;11(6):985-90. doi: 10.1016/s0968-0896(02)00517-5.

Abstract

N-(2-Mercaptoethyl)glycine [NMGly] was incorporated into the 3 and 5 positions of angiotensin II and oxidized to give the corresponding cyclized disulfide c[NMGly(3,5)]Ang II. The binding affinity to the angiotensin II receptor (AT(1)) of this conformationally constrained analogue, which is related to the potent Ang II agonist c[Hcy(3,5)]Ang II, was examined. The analogue had no affinity to the AT(1) receptor. Theoretical conformational analysis was performed to compare the conformational characteristics of model compounds of c[Hcy(3,5)]Ang II and the frame shifted analogue c[NMGly(3,5)]Ang II in an attempt to explain the lack of affinity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / analogs & derivatives*
  • Angiotensin II / chemistry
  • Angiotensin II / metabolism
  • Animals
  • CHO Cells
  • Cell Division / drug effects
  • Chemical Phenomena
  • Chemistry, Physical
  • Cricetinae
  • Disulfides / chemistry*
  • Indicators and Reagents
  • Peptides / chemical synthesis
  • Protein Conformation
  • Radioligand Assay
  • Rats
  • Receptor, Angiotensin, Type 1 / drug effects
  • Receptor, Angiotensin, Type 1 / metabolism

Substances

  • Disulfides
  • Indicators and Reagents
  • Peptides
  • Receptor, Angiotensin, Type 1
  • Angiotensin II